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Lupus erythematosus is thought by clinicians to be common 
in Cape Town, particularly in people of mixed ancestry, 
although no accurate epidemiological figures are available 
to confirm this impression. A diagnosis of discoid lupus 
erythematosus (DLE) can frequently be made on clinical 
grounds.1 Where the diagnosis is in doubt, histological 
confirmation is sought, but biopsy is not a routine procedure 
in clinically characteristic cases. Cutaneous squamous cell 
carcinoma (SCC) is seen in some of these patients, as a 
complication of this chronic inflammatory skin disease, but 
has not previously been reported in southern Africa. We 
report on 2 black African women with SCC occurring in 
longstanding DLE lesions. 
Case 1
A 40-year-old black South African woman with DLE, a heavy 
smoker and chronic alcohol abuser, had previously been 
seen at the Dermatology Clinic at Groote Schuur Hospital 
in 2001. At the time she had been given oral chloroquine 
phosphate and topical betamethasone valerate for 1 month. 
According to the usual practice in this dermatology clinic, 
biopsy confirmation was not sought as a confident clinical 
diagnosis was made. Thereafter, she had been lost to 
follow-up, with no further treatment. She presented again 
in September 2004 with a large ulcerative lesion on the 
upper lip, present for 4 months. The oral commissures were 
uninvolved. Biopsy showed moderately differentiated SCC. 
Her DLE was clinically inactive at this stage and review 
of the results of histological examination of skin adjacent 
to her tumour showed epidermal atrophy and follicular 
plugging, compatible with late DLE.  She underwent wide 
local excision of the tumour and bilateral neck dissections. 
Reconstruction of the upper lip defect was done using 
the Abbey lip switch technique. The left neck dissection 
specimen had 1 positive node out of 27 and the right neck 
dissection had 2 positive nodes out of 18. The patient is 
currently undergoing radiotherapy. 
Case 2 
A 45-year-old woman of mixed ancestry (Fig. 1) had 
previously been treated at the Dermatology Clinic at Groote 
Schuur Hospital between 1982 and 1989 for DLE, with oral 
chloroquine phosphate and topical betamethasone valerate. 
She presented to the clinic again in 2004, with a 2 x 2 cm 
ulcerative lesion of the lower lip, present for 2 months and 
involving the vermillion border close to the right commissure. 
She was a heavy smoker and drinker. Biopsy showed SCC. 
The original diagnosis of DLE was based on classic clinical 
findings, in line with current practice in this clinic. Review 
of the results of histological examination of the skin adjacent 
to the tumour showed mild focal interface changes and 
a lymphocytic infiltrate in the upper dermis and peri-
adnexal areas. This is compatible with, but not diagnostic 
of underlying DLE. Wide local excision of the tumour and a 
right neck dissection were performed. Reconstruction of the 
lip defect was done using Benard-Webster local advancement 
flaps. Histological examination revealed that the right neck 
dissection specimen was pathologically not involved. 
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Case Report
Summary
squamous cell carcinoma has rarely been reported in 
black african people, with only 11 cases reported in the 
world literature to date. We report on 2 further cases, the 
first to be reported in southern Africa, of squamous cell 
carcinoma in lesions of discoid lupus erythematosus
SAJS
Fig. 1. Patient with DLE on the lips, nose and malar area and 
SCC of the lower lip.
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Discussion 
SCC comprises approximately 20% of all skin cancer.2 Skin 
cancer is rare in black people, occasionally occurring as a 
complication of chronic inflammatory skin disease, in sinus 
tracts and in scars.3 The occurrence of SCC in black people 
with DLE is reported infrequently, although this may not 
reflect the actual incidence. It has been observed in several 
previous patients in Cape Town, but has not been reported in 
the literature. 
   In 1993 Sherman et al.2 analysed 10 patients who had been 
reported in the literature and including most of those who 
had previously been reported by Caruso et al.4 in 1987. They 
failed to include 1 patient reported by Dabski et al.5 in 1986. 
In total, 11 black people with SCC and DLE have been 
reported in the world literature and all have been African-
Americans in the USA and Jamaica. To the best of our 
knowledge, our patients are the first 2 black patients to be 
reported from southern Africa. The clinical features of cases 
reported in the world literature are summarised in Table I. 
The number of cases is still too small to allow for statistical 
analysis of the data. 
   The initial reports suggested a male predominance.2,4 
However as more cases are being reported there appears to 
be a female predominance, possibly reflecting the gender 
ratio seen in DLE. 
   The geographical location (sunbelt areas) of the patients 
in Table I and location of the SCC lesions in sun-exposed 
areas of the body support the role of sunshine as an 
aetiological factor. The mechanism of ultraviolet (UV)-
induced photocarcinogenesis appears to involve inactivation 
of the p53 tumour suppressor gene and multiple exposures 
are believed to be needed to inactivate p53 and initiate and 
promote the development of SCC.12
   The development of SCC in black patients with DLE may 
be related to the lack of protective melanin pigment. This 
exposes the affected areas to the UVB component of sunlight 
involved in cutaneous carcinogenesis. An additional factor is 
likely to be the presence of chronic inflammation in DLE, as 
in chronic ulcers or burn wounds (Marjolin’s ulcer).
   Seven of the 13 cases reported in Table I involved the 
lips. The frequency of DLE-associated SCC at this site 
may reflect the level of UV exposure. A study in Beijing13 
identified DLE as a co-factor in 10 of 181 people with SCC 
of the lip (5.5%).
Conclusion
We report on 2 cases of SCC in black patients with DLE, 
thought to be the first reported in southern Africa. This 
report serves to emphasise that DLE may be an additional 
background factor in the development of SCC of the skin. 
As black patients with DLE in sun-exposed areas of the body 
may be at risk of developing SCC in their skin lesions, every 
effort should be made to prevent direct sun exposure to the 
affected areas of the body, with behaviour modification and 
the daily use of high-factor UVA/UVB sunscreens.  Regular 
follow-up, with prompt biopsy of any suspicious lesions, 
should be encouraged.14
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